An analysis published earlier this year found that patients taking GLP-1 medications experienced lower rates of both alcohol use disorder and other substance use disorders compared with similar patients taking different diabetes medications, a finding that prompted researchers to investigate the drugs' potential more directly through a controlled clinical trial
This ensures that what is on the label is actually in the bottle and that the product is free from heavy metals or contaminants
2 DUAL-II The 26-week, double-blind DUAL-II study (n=413) compared the combination with insulin degludec alone in patients already receiving 2040 units basal insulin daily plus metformin with or without sulfonylurea/prandial glucose regulator ('glinide')
Contact our team for current pricing details
Judi Chervenak, MD, an attending physician at Montefiore Einstein and an associate professor of reproductive endocrinology and infertility at Albert Einstein College of Medicine
However, patients should understand that ongoing monitoring remains essential